Skip to Main Content

Paper Details

A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.
Journal of Infectious Diseases
22
2020
Adenosine, CD14, CD163, CD38+, CD4, CD4+, CD4+ T-cell, CD8, CD8+, CD8+ T-cell, Dipyridamole, HIV, HIV-1 infection, HLA, Human, Human Immunodeficiency Virus, T-cell, Virally, adenosine, chronic inflammation, cyclic adenosine monophosphate, dipyridamole, human, human immunodeficiency virus (HIV) type, inosine, interleukin 6, nucleoside, participants, persons
Author NameAffiliation
Sharon A RiddlerUniversity of Pittsburgh School of Medicine
Sharon A RiddlerUniversity of Pittsburgh Graduate School of Public Health
  • 1 - 2

Datasets

Release 1.2